Wong Roderick (CIK 0001493280)

Latest company ownership

Shares held
8,306,063
Last filed at
May 1, 2025
Confidence Score
52.1
2025Q4
Confidence Score History
2022Q3 2025Q4
Shares held
3,995,000
Last filed at
Aug 6, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
3,544,248
Last filed at
Nov 12, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Shares held
3,256,102
Last filed at
Mar 24, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Shares held
2,013,601
Last filed at
May 7, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
ATHA - Athira Pharma, Inc.
Role: 10% Owner
Shares held
1,535,131
Last filed at
Sep 22, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
TELA - TELA Bio, Inc.
Role: 10% Owner
Shares held
1,139,358
Last filed at
Dec 18, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
902,498
Last filed at
Dec 13, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
3,325
Last filed at
Jun 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 19, 2025 Sep 23, 2025 ROCKET PHARMACEUTICALS, INC. Director Sell 17.5 -1,100,000 -1.97% ✗ $3.4M
Apr 30, 2025 May 1, 2025 Orchestra BioMed Holdings, Inc. 10% Owner Buy 72.5 +49,900 0.60% ✗ $149.2K
Apr 29, 2025 Apr 29, 2025 Orchestra BioMed Holdings, Inc. 10% Owner Buy 72.5 +50,000 0.61% ✗ $126.5K
Jan 24, 2023 Jan 26, 2023 Orchestra BioMed Holdings, Inc. CEO Buy 100.0 +1,808,512 180.85% ✗ $18.1M
Oct 6, 2022 Oct 11, 2022 ROCKET PHARMACEUTICALS, INC. Director Buy 97.5 +1,355,932 8.33% ✗ $20M
Jul 22, 2022 Jul 25, 2022 Orchestra BioMed Holdings, Inc. CEO Buy 100.0 +1,000,000 100.00% ✗ $10M
Aug 4, 2021 Aug 6, 2021 Avidity Biosciences, Inc. MP and CIO Buy 100.0 +800,000 20.03% ✗ $14.4M
May 11, 2021 May 13, 2021 ROCKET PHARMACEUTICALS, INC. Director Sell 15.0 -725,000 -4.48% ✗ $29M
May 7, 2021 May 7, 2021 Tarsus Pharmaceuticals, Inc. 10% Owner Sell 15.0 -450,000 -18.27% ✗ $13.5M
Dec 10, 2020 Dec 14, 2020 ROCKET PHARMACEUTICALS, INC. Director Buy 90.0 +247,720 1.43% ✗ $13.9M
Sep 18, 2020 Sep 22, 2020 Athira Pharma, Inc. 10% Owner Buy 100.0 +750,000 39.08% ✗ $12.8M
Jun 16, 2020 Jun 16, 2020 Avidity Biosciences, Inc. Director Buy 100.0 +950,000 31.20% ✗ $17.1M
Mar 18, 2020 Mar 19, 2020 Milestone Pharmaceuticals Inc. 10% Owner Buy 60.0 +8,575 0.20% ✗ $91.8K
Mar 2, 2020 Mar 19, 2020 Milestone Pharmaceuticals Inc. 10% Owner Buy 87.5 +78,263 1.85% ✗ $1.5M
Jan 13, 2020 Jan 13, 2020 Milestone Pharmaceuticals Inc. 10% Owner Buy 95.0 +270,000 6.82% ✗ $4.4M
Dec 30, 2019 Jan 2, 2020 Milestone Pharmaceuticals Inc. 10% Owner Buy 75.0 +22,771 0.58% ✗ $353K
Dec 17, 2019 Dec 18, 2019 TELA Bio, Inc. 10% Owner Sell 20.0 -36,000 -3.06% ✗ $407.6K
Dec 13, 2019 Dec 17, 2019 TELA Bio, Inc. 10% Owner Buy 85.0 +23,900 2.08% ✗ $277.1K
Dec 11, 2019 Dec 13, 2019 Immunovant, Inc. CEO Buy 90.0 +31,500 3.62% ✗ $344K
Dec 10, 2019 Dec 12, 2019 ROCKET PHARMACEUTICALS, INC. Director Buy 88.8 +225,000 1.32% ✗ $5M
Dec 10, 2019 Dec 10, 2019 Immunovant, Inc. CEO Buy 90.0 +25,971 3.07% ✗ $269.5K
Dec 6, 2019 Dec 9, 2019 Immunovant, Inc. CEO Buy 92.5 +50,000 6.29% ✗ $510.1K
Dec 6, 2019 Dec 9, 2019 Immunovant, Inc. CEO Buy 100.0 +400,000 101.26% ✗ $4.1M
Dec 5, 2019 Dec 5, 2019 Immunovant, Inc. CEO Buy 90.0 +20,000 5.33% ✗ $203K
Dec 4, 2019 Dec 4, 2019 Immunovant, Inc. CEO Buy 90.0 +20,000 5.63% ✗ $203K
Nov 29, 2019 Dec 3, 2019 Immunovant, Inc. CEO Buy 97.5 +66,918 23.23% ✗ $693.5K
Nov 25, 2019 Nov 29, 2019 Immunovant, Inc. CEO Buy 87.5 +12,000 4.35% ✗ $125.9K
Nov 20, 2019 Nov 22, 2019 Immunovant, Inc. CEO Buy 97.5 +46,999 20.51% ✗ $489K
Nov 20, 2019 Nov 22, 2019 Milestone Pharmaceuticals Inc. 10% Owner Buy 100.0 +400,000 11.31% ✗ $6.4M
Nov 15, 2019 Nov 19, 2019 Immunovant, Inc. CEO Buy 97.5 +72,610 46.40% ✗ $744.8K
Nov 12, 2019 Nov 14, 2019 Immunovant, Inc. CEO Buy 100.0 +126,000 413.11% ✗ $1.3M
Nov 8, 2019 Nov 12, 2019 Stoke Therapeutics, Inc. 10% Owner Sell 37.5 -16,434 -0.46% ✗ $471.6K
Nov 7, 2019 Nov 12, 2019 Immunovant, Inc. CEO Buy 97.5 +30,500 100.00% ✗ $310.5K
Nov 4, 2019 Nov 6, 2019 Stoke Therapeutics, Inc. 10% Owner Buy 92.5 +104,873 3.03% ✗ $3.1M
Oct 30, 2019 Nov 1, 2019 Stoke Therapeutics, Inc. 10% Owner Buy 87.5 +68,783 2.03% ✗ $2M
Oct 10, 2019 Oct 15, 2019 Milestone Pharmaceuticals Inc. 10% Owner Buy 60.0 +5,487 0.16% ✗ $95.5K
Oct 1, 2019 Oct 3, 2019 Milestone Pharmaceuticals Inc. 10% Owner Buy 65.0 +8,150 0.23% ✗ $145K
Oct 1, 2019 Oct 2, 2019 Stoke Therapeutics, Inc. 10% Owner Buy 75.0 +31,560 0.94% ✗ $693K
Jun 19, 2019 Jun 20, 2019 Stoke Therapeutics, Inc. 10% Owner Buy 100.0 +555,556 19.84% ✗ $10M
May 9, 2019 May 9, 2019 Milestone Pharmaceuticals Inc. 10% Owner Buy 100.0 +666,667 23.35% ✗ $10M
Apr 16, 2019 Apr 18, 2019 ROCKET PHARMACEUTICALS, INC. Director Buy 93.8 +550,005 3.33% ✗ $9.6M